N-methylsuccinimide: in human urine and plasma is determined by organic solvent, N-methyl-2-pyrrolidone(NMP); structure for MSI in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 70717 |
| CHEMBL ID | 317929 |
| SCHEMBL ID | 27941 |
| MeSH ID | M0287560 |
| Synonym |
|---|
| AC-15701 |
| ai3-07107 |
| CHEMBL317929 |
| nsc11324 |
| succinimide, n-methyl- |
| 1-methyl-2,5-pyrrolidinedione |
| 1121-07-9 |
| n-methylsuccinimide |
| nsc-11324 |
| n-methyl succinimide |
| 1-methylpyrrolidine-2,5-dione |
| 2,5-pyrrolidinedione, 1-methyl- |
| inchi=1/c5h7no2/c1-6-4(7)2-3-5(6)8/h2-3h2,1h |
| n-methylsuccinimide, 99% |
| AKOS002845657 |
| M2207 |
| 1-methyl-pyrrolidine-2,5-dione |
| ft9gt286w2 , |
| unii-ft9gt286w2 |
| nsc 11324 |
| FT-0608047 |
| SCHEMBL27941 |
| DTXSID40149902 |
| J-002708 |
| mfcd00005517 |
| DS-5966 |
| Q27462406 |
| AMY228 |
| n-methyl-2,5-pyrrolidinedione |
| STL444522 |
| D70368 |
| A894650 |
| EN300-211529 |
| CS-0151201 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID28486 | Second-order rate constant (M-1 s-1) for the alkaline hydrolysis in water at 30 degrees C | 2002 | Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13 | Acylating agents as enzyme inhibitors and understanding their reactivity for drug design. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (38.53) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||